Human papillomavirus vaccines: organisation and experience of preclinical studies
INTRODUCTION. Vaccination is the main measure for the primary prevention of human papillomavirus (HPV)-related diseases. The development of novel vaccine candidates is underway worldwide, including in the Russian Federation. At the same time, the clinical introduction of new HPV vaccines is seriousl...
Saved in:
| Main Authors: | A. S. Korovkin, T. N. Nikitina, T. Yu. Kozlova, D. V. Gorenkov, A. R. Volgin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-10-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human papillomavirus vaccine uptake in South Korea
by: Jin Young Choi, et al.
Published: (2022-01-01) -
Overview of the Global Vaccination against Human Papillomavirus
by: Leyla S. Namazova-Baranova, et al.
Published: (2018-02-01) -
Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands
by: Birgit Sollie, et al.
Published: (2025-06-01) -
Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
by: Ashenafi Kibret Sendekie, et al.
Published: (2025-01-01) -
Vaccination against HPV: Theoretical Aspects and Practical Results of Cervical Cancer Prevention
by: N. V. Zarochentseva, et al.
Published: (2020-01-01)